Cheng Sohanya Roshan 4
4 · Karyopharm Therapeutics Inc. · Filed Sep 5, 2024
Insider Transaction Report
Form 4
Cheng Sohanya Roshan
EVP & Chief Commercial Officer
Transactions
- Sale
Common Stock
2024-09-04$0.72/sh−5,356$3,866→ 404,051 total
Footnotes (2)
- [F1]This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 7, 2022, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.
- [F2]Includes 15,898 shares acquired under the Karyopharm Therapeutics Inc. Amended & Restated 2013 Employee Stock Purchase Plan on April 30, 2024.